Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 358

1.

Anti-mitochondrial antibodies and primary biliary cirrhosis in TGF-beta receptor II dominant-negative mice.

Oertelt S, Lian ZX, Cheng CM, Chuang YH, Padgett KA, He XS, Ridgway WM, Ansari AA, Coppel RL, Li MO, Flavell RA, Kronenberg M, Mackay IR, Gershwin ME.

J Immunol. 2006 Aug 1;177(3):1655-60.

2.

Natural killer T cells exacerbate liver injury in a transforming growth factor beta receptor II dominant-negative mouse model of primary biliary cirrhosis.

Chuang YH, Lian ZX, Yang GX, Shu SA, Moritoki Y, Ridgway WM, Ansari AA, Kronenberg M, Flavell RA, Gao B, Gershwin ME.

Hepatology. 2008 Feb;47(2):571-80.

PMID:
18098320
3.
4.

Adoptive transfer of CD8(+) T cells from transforming growth factor beta receptor type II (dominant negative form) induces autoimmune cholangitis in mice.

Yang GX, Lian ZX, Chuang YH, Moritoki Y, Lan RY, Wakabayashi K, Ansari AA, Flavell RA, Ridgway WM, Coppel RL, Tsuneyama K, Mackay IR, Gershwin ME.

Hepatology. 2008 Jun;47(6):1974-82. doi: 10.1002/hep.22226.

5.

Comparative studies of antimitochondrial autoantibodies in sera and bile in primary biliary cirrhosis.

Nishio A, Van de Water J, Leung PS, Joplin R, Neuberger JM, Lake J, Björkland A, Tötterman TH, Peters M, Worman HJ, Ansari AA, Coppel RL, Gershwin ME.

Hepatology. 1997 May;25(5):1085-9.

PMID:
9141421
6.

Monoclonal antibodies to mitochondrial E2 components define autoepitopes in primary biliary cirrhosis.

Migliaccio C, Nishio A, Van de Water J, Ansari AA, Leung PS, Nakanuma Y, Coppel RL, Gershwin ME.

J Immunol. 1998 Nov 15;161(10):5157-63.

7.

IL-2 receptor alpha(-/-) mice and the development of primary biliary cirrhosis.

Wakabayashi K, Lian ZX, Moritoki Y, Lan RY, Tsuneyama K, Chuang YH, Yang GX, Ridgway W, Ueno Y, Ansari AA, Coppel RL, Mackay IR, Gershwin ME.

Hepatology. 2006 Nov;44(5):1240-9.

PMID:
17058261
8.

Experimental autoimmune cholangitis: a mouse model of immune-mediated cholangiopathy.

Jones DE, Palmer JM, Kirby JA, De Cruz DJ, McCaughan GW, Sedgwick JD, Yeaman SJ, Burt AD, Bassendine MF.

Liver. 2000 Oct;20(5):351-6.

PMID:
11092252
9.

Animal models of primary biliary cirrhosis: materials and methods.

Leung PS, Yang GX, Dhirapong A, Tsuneyama K, Ridgway WM, Gershwin ME.

Methods Mol Biol. 2012;900:291-316. doi: 10.1007/978-1-60761-720-4_14.

PMID:
22933075
10.

Persistence of autoantibodies against recombinant mitochondrial and nuclear pore proteins after orthotopic liver transplantation for primary biliary cirrhosis.

Mattalia A, Lüttig B, Rosina F, Leung PS, Van de Water J, Bauducci M, Ciancio A, Böker KH, Worman H, Cooper RL, Manns M, Ansari A, Rizzetto M, Gershwin ME.

J Autoimmun. 1997 Oct;10(5):491-7.

PMID:
9376077
11.

Overexpression of microRNA-21 is associated with elevated pro-inflammatory cytokines in dominant-negative TGF-β receptor type II mouse.

Ando Y, Yang GX, Kenny TP, Kawata K, Zhang W, Huang W, Leung PS, Lian ZX, Okazaki K, Ansari AA, He XS, Invernizzi P, Ridgway WM, Lu Q, Gershwin ME.

J Autoimmun. 2013 Mar;41:111-9. doi: 10.1016/j.jaut.2012.12.013.

13.

Evidence for the targeting by 2-oxo-dehydrogenase enzymes in the T cell response of primary biliary cirrhosis.

Van de Water J, Ansari AA, Surh CD, Coppel R, Roche T, Bonkovsky H, Kaplan M, Gershwin ME.

J Immunol. 1991 Jan 1;146(1):89-94.

PMID:
1984455
14.

Cytokine profile of liver-infiltrating CD4+ T cells separated from murine primary biliary cirrhosis-like hepatic lesions induced by graft-versus-host reaction.

Itoh S, Matsuzaki Y, Kimura T, Ikegami T, Shoda J, Fujiwara M, Tanaka N.

J Gastroenterol Hepatol. 2000 Apr;15(4):443-51.

PMID:
10824891
15.

The immunobiology and pathophysiology of primary biliary cirrhosis.

Hirschfield GM, Gershwin ME.

Annu Rev Pathol. 2013 Jan 24;8:303-30. doi: 10.1146/annurev-pathol-020712-164014. Review.

PMID:
23347352
16.

Primary biliary cirrhosis is characterized by IgG3 antibodies cross-reactive with the major mitochondrial autoepitope and its Lactobacillus mimic.

Bogdanos DP, Baum H, Okamoto M, Montalto P, Sharma UC, Rigopoulou EI, Vlachogiannakos J, Ma Y, Burroughs AK, Vergani D.

Hepatology. 2005 Aug;42(2):458-65.

PMID:
16025495
17.

Immunoglobulin gene usage and immunohistochemical characteristics of human monoclonal antibodies to the mitochondrial autoantigens of primary biliary cirrhosis induced in the XenoMouse.

Sasaki M, Van De Water J, Kenny TP, Gallo ML, Leung PS, Nakanuma Y, Ansari AA, Coppel RL, Neuberger J, Gershwin ME.

Hepatology. 2001 Oct;34(4 Pt 1):631-7.

PMID:
11584357
18.

Identification and precursor frequency analysis of a common T cell epitope motif in mitochondrial autoantigens in primary biliary cirrhosis.

Shimoda S, Van de Water J, Ansari A, Nakamura M, Ishibashi H, Coppel RL, Lake J, Keeffe EB, Roche TE, Gershwin ME.

J Clin Invest. 1998 Nov 15;102(10):1831-40.

19.

Mouse mammary tumor virus in anti-mitochondrial antibody producing mouse models.

Zhang G, Chen M, Graham D, Subsin B, McDougall C, Gilady S, Kneteman M, Law L, Swain M, Trauner M, Wrzesinski S, Flavell R, Wasilenko S, Mason A.

J Hepatol. 2011 Oct;55(4):876-84. doi: 10.1016/j.jhep.2011.01.037.

PMID:
21334408
20.

CD4 T-cell autoreactivity to the mitochondrial autoantigen PDC-E2 in AMA-negative primary biliary cirrhosis.

Shimoda S, Miyakawa H, Nakamura M, Ishibashi H, Kikuchi K, Kita H, Niiro H, Arinobu Y, Ono N, Mackay IR, Gershwin ME, Akashi K.

J Autoimmun. 2008 Sep;31(2):110-5. doi: 10.1016/j.jaut.2008.05.003.

PMID:
18644699

Supplemental Content

Support Center